By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Markets > Stocks > UBS sees margins improving at Aramark, upgrades stock to Outperform
Stocks

UBS sees margins improving at Aramark, upgrades stock to Outperform

News Room
Last updated: 2023/08/23 at 10:14 AM
By News Room
Share
2 Min Read
SHARE

© Reuters. UBS sees margins improving at Aramark (ARMK), upgrades stock to Outperform

UBS upgraded Aramark (NYSE:) to a Buy rating (From Neutral) and reiterated their 12-month price target on the stock of $43.00 as analysts believe the American food service provider is approaching margin inflection.

The analysts wrote in a note, “we believe Aramark is approaching margin inflection in FQ4 (Sept) with average gross margin expansion potential of nearly 200bps yoy over the next four quarters.”

The growth is being influenced by a decrease in food inflation, as specific components of food expenses appear to be declining in the United States in the upcoming period. At the same time, Aramark is actively introducing higher prices in specific sectors where pricing has not kept up with overall inflation. This strategic adjustment in pricing is fostering a better balance between prices and costs, which is expected to contribute to a recovery in gross margins.

If ARMK were to fully achieve this goal, the analysts believe it would result in the company posting upsides to street estimates. Meanwhile, the stock’s ~15% pullback over the past month creates an attractive opportunity relative to the UBS price target.

UBS has revised its short-term margin predictions for the stock to account for a more advantageous price-cost situation. As a result, the projected EPS for the fiscal year 2023 has been adjusted upward from $1.70 to $1.72, and the estimated EPS for the fiscal year 2024 has been raised to $2.40 compared to the previous $2.32. This adjustment is attributed to an improved AOI margin, which is now at 6.3%, representing a 20 basis points increase.

Shares of ARMK are up 2.11% in mid-day trading Tuesday.

Read the full article here

News Room August 23, 2023 August 23, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Why retail investors now have a ‘seat at the table’ on Wall Street

Watch full video on YouTube

Worthington Enterprises: Upgrade To Buy On Improved Fundamentals (NYSE:WOR)

This article was written byFollowI focus on long-term investments while incorporating short-term…

EU will lose ‘race to the bottom’ on regulation, says competition chief

Stay informed with free updatesSimply sign up to the EU business regulation…

Why beef prices are soaring

Watch full video on YouTube

Opendoor is an AI stock: Analyst

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

Stocks

CPS reports solid 2023 performance, eyes future growth By Investing.com

By News Room
Stocks

Niu Technologies faces mixed results in Q4 2023 By Investing.com

By News Room
Stocks

Exagen Inc. reports strong 2023 revenue growth By Investing.com

By News Room
Stocks

Legacy Housing reports mixed results amid sales decline By Investing.com

By News Room
Stocks

Harmony Biosciences exec sells over $383k in stock By Investing.com

By News Room
Stocks

Biofrontera posts record revenue and outlines growth plans By Investing.com

By News Room
Stocks

Granite Ridge CFO buys $31,000 in company stock By Investing.com

By News Room
Stocks

Coliseum Capital Management buys MasterCraft Boat shares worth over $3.2m By Investing.com

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?